Kahveci, A. M. and Tahan, V. (2016) “Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies”, Turkish Journal of Gastroenterology, 27(1), pp. 89–90. doi: 10.5152/tjg.2015.150012.